Background For resource‐poor countries, affordable methods are required for enumeration of CD4+ T lymphocytes of HIV‐positive patients. For infants, additional determination of CD4/CD8 ratio is needed. Methods We determine the CD4+ and CD8+ T lymphocytes as the CD3+CD4+ and CD3+CD8+ population of blood cells. Target cells are CD3‐immunomagnetically separated from the whole blood, and CD4‐Phycoerythrin and CD8‐PerCP immunofluorescently labeled. A point‐of‐care single platform image cytometer was developed to enumerate the target CD3+CD4+ and CD3+CD8+ populations. It has light‐emitting diodes illumination, is fully computer‐controlled, operates from a 12 V battery, and was designed to be cheap and easy‐to‐handle. Target cells are imaged on a CCD camera and enumerated by an image analysis algorithm. The cytometer outputs the absolute number of CD4+ and CD8+ T lymphocytes/μl and CD4/CD8 ratio. Results The quality of the cell images obtained with the cytometer is sufficient for a reliable enumeration of target cells. The image cytometer achieves an accuracy of better than 10% in the range of 50–1700 cells/μl. Analysis of blood samples from HIV patients yields a good agreement with the TruCount method for CD4 and CD8 count and CD4/CD8 ratio. Conclusions The image cytometer is affordable (component costs $3,000), compact (25 × 25 × 20 cm3), and uses disposable test materials, making it a good candidate to monitor progression of immunodeficiency disease in resource‐poor settings. © 2007 International Society for Analytical Cytology.
Background: HIV monitoring in resource-constrained settings demands affordable and reliable CD4 + T lymphocytes enumeration methods. We developed a simple single platform image cytometer (SP ICM), which is a dedicated volumetric CD4 + T lymphocytes enumeration system that uses immunomagnetic and immunofluorescent technologies. The instrument was designed to be a low-cost, yet reliable and robust one. In this article we test the instrument and the immunochemical procedures used on blood from HIV negative and HIV positive patients.Methods
Background: We developed a volumetric single platform image cytometer (SP ICM) that is dedicated to count CD4 1 and CD8 1 T lymphocytes for HIV monitoring in resource-constrained settings. The instrument was designed to be low-cost, yet reliable, easy-to-use, and robust.Methods: Whole blood is incubated with CD3-magnetic nanoparticles, CD4-phycoerythrin (PE), and CD8-peridinin-chlorophyll-protein complex (PerCP). The CD3 cells are immunomagnetically attracted to an analysis surface, where fluorescence images of CD4 1 and CD8 1 T lymphocytes are recorded and analyzed, respectively. We compared CD4, CD8 counts, and CD4/CD8 ratio obtained by the SP ICM with those from a SP flow cytometer (FCM) tetraCXP method on blood samples from 145 patients.Results: Good correlations were obtained (R: 0.96-0.99) between the SP ICM and the SP FCM. There was 10% CD8 undercount in the SP ICM, which could be partly caused by CD8 1dim T lymphocytes that were not detected by the instrument or not counted by the image analysis due to the cross-talk from the CD4-PE signal in the CD8-PerCP image.Conclusions: The SP ICM is a good candidate for HIV monitoring in point-of-care settings of resourceconstrained countries. q
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.